Venture capital investment trends from 2022 are expected to continue in 2023, as investors evaluate economic headwinds and take a cautious approach to see how conditions evolve. … READ MORE >
venture capital
Venture capital activity slows even as deal counts and fundraising hit records
Venture capital deal and exit activity for the first nine months of the year were well below the explosive pace set in 2021 as various headwinds set in during the third quarter to cool off the blazing trends that had prevailed since the second quarter of 2020. … READ MORE >
Hybrid funds emerge as a growing force in venture capital: Spring 2022 outlook
As interest in venture capital continues to grow, more flexible structures including hybrid funds will emerge to cater to the needs of investors and blur the lines between open-end and closed-end structures. … READ MORE >
In booming year, venture capital shows no signs of slowing
In the United States alone, $82.8 billion of capital was deployed in the third quarter, bringing the year-to-date amount up to $238.7 billion. … READ MORE >
5 things to know in life sciences: Week of October 11
Each week we highlight five things you need to know in the life sciences industry. … READ MORE >
Private equity and venture capital stay resilient in the EU and UK
After a year of upheaval, private equity and venture capital dealmaking ended last year on a strong note in the European Union and the U.K., and that momentum is poised to continue. … READ MORE >
CHART OF THE DAY: Venture capital investment in health tech on track for record year
North American investment in venture capital-backed health technology and digital health companies hit a record through the first 10 months of the year, outpacing all of 2019 with two months to go. … READ MORE >
Venture capital tech investments show strength in first half of 2019
For cash-intensive technology companies, access to capital is often required to sustain operations and quickly achieve scale. Venture capital firms invested over $30 billion in tech startups in the second quarter of 2019, according to data from Pitchbook, putting total investment on pace to eclipse $100 billion for the second straight year. … READ MORE >
Biotech needs cash in hesitant market
Life science companies require a cash infusion at least twice as big as that of 2018 to fund research and development at a time when investors remain skittish, according to a Bloomberg analysis. … READ MORE >